IRCT20221017056209N1
Comparison of the effect of medroxyprogesterone acetate and black seed extract on the symptoms of polycystic ovary syndrome in adolescent girls
Gonabad University of Medical Sciences·Phase 1·Iranian Registry Of Clinical Trial·drugRecruiting
Study focus
- Disease/Condition
- Polycystic ovarian syndrome
- Study type
- Interventional
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- Gonabad University of Medical Sciences
- Location
- Iran
Timeline & enrollment
- Phase
- Phase 1
- Start date
- Oct 22, 2022
- End date
- N/A
ICD-10 classifications
Polycystic ovarian syndromeOvarian dysfunction, unspecifiedOvarian dysfunctionOther ovarian dysfunctionOther and unspecified ovarian cysts
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT20221017056209N1
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT20221017056209N1 through Pure Global AI's free database. This Phase 1 trial is sponsored by Gonabad University of Medical Sciences and is currently Recruiting. The study focuses on Polycystic ovarian syndrome.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.